Illustrative image – not actual.Globalpharma LLC, a joint venture company between Kopran and Dubai Investment Corp. has commenced commercial production at its formulations unit in Jebel Ali Industrial Area of Dubai.
The project was estimated to cost Rs.94 crore and was scheduled to be commissioned in December 2001.
The company is also in process of tying up for contract manufacturing, apart from marketing its own products and it would register its products in all the GCC countries and will seek UK MCA, European Union and US FDA approval to supply its products globally.
